Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Calcium Channel Blockers Less Effective than Diuretics

By HospiMedica staff writers
Posted on 25 Sep 2000
An meta-analysis of nine studies involving more than 27,000 patients has revealed that calcium channel blockers are less effective than other, less-costly drugs in preventing complications of high blood pressure such as congestive heart failure and heart attacks. More...
The other drugs used by patients in the analysis included diuretics, beta blockers, and angiotensin-converting enzyme (ACE) inhibitors. The meta-analysis was conducted by a team of researchers from Wake Forest University School of Medicine (Winston-Salem, NC, USA), the University of Washington (Seattle, USA), and the Albert Einstein College of Medicine (New York, NY, USA) and reported at a meeting of the European Society of Cardiology in Amsterdam.

Although calcium channel blockers do not harm patients, they are less effective and therefore the users do not enjoy the protection against heart attacks and heart failure that they would receive from other antihypertensive drugs. The researchers found that patients treated with calcium channel blockers had a 27% higher risk of heart attack and a 26% higher risk of heart failure than other patients. They found no difference, however, in the number of deaths from all causes or the risk of stroke. All drugs, including the calcium channel blockers, lowered blood pressure by the same amount. These results show that preventing heart attacks is more complicated than simply lowering blood pressure to a normal level.

According to the team's leader, Dr. Curt D. Furberg of the Wake Forest University School of Medicine, calcium channel blockers cost 12-15 times the cost of a diuretic drug. Dr. Furberg says low-dose diuretics should be considered standard therapy for hypertension and all new classes of drugs should be compared to them.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.